Studies have shown that circCCDC66 significantly inhibits B-cell lymphoma-2 (BCL2) mRNA and protein levels by targeting miR-618 to induce cisplatin chemotherapy resistance in gastric cancer cells. The gene discussed is BCL2; the disease is gastric cancer.